{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:04:43Z","timestamp":1785708283172,"version":"3.56.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"DOI":"10.1097\/qai.0b013e31823e31f7","type":"journal-article","created":{"date-parts":[[2011,11,8]],"date-time":"2011-11-08T09:44:34Z","timestamp":1320745474000},"page":"126-133","source":"Crossref","is-referenced-by-count":86,"title":["A Randomized, Double-Blind, Controlled Study of NGX-4010, a Capsaicin 8% Dermal Patch, for the Treatment of Painful HIV-Associated Distal Sensory Polyneuropathy"],"prefix":"10.1097","volume":"59","author":[{"given":"David B.","family":"Clifford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Moyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce J.","family":"Brew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey K.","family":"Tobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geertrui F.","family":"Vanhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210131","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4065\/81.2.213","article-title":". Human immunodeficiency virus-associated peripheral neuropathies.","volume":"81","author":"Ferrari","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"R2-5-20210131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1046\/j.1529-8027.2001.006001008.x","article-title":"Epidemiology and clinical features of HIV-1 associated neuropathies.","volume":"6","author":"Verma","year":"2001","journal-title":"J Peripher Nerv Syst"},{"key":"R3-5-20210131","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1212\/01.wnl.0000218303.48113.5d","article-title":". HIV neuropathy natural history cohort study: assessment measures and risk factors.","volume":"66","author":"Simpson","year":"2006","journal-title":"Neurology"},{"key":"R4-5-20210131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0304-3959(96)03281-2","article-title":". Pain syndromes and etiologies in ambulatory AIDS patients.","volume":"70","author":"Hewitt","year":"1997","journal-title":"Pain"},{"key":"R5-5-20210131","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archneur.61.4.546","article-title":". HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.","volume":"61","author":"Morgello","year":"2004","journal-title":"Arch Neurol"},{"key":"R6-5-20210131","first-page":"153","article-title":"Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.","volume":"9","author":"Simpson","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R7-5-20210131","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/00002030-200211080-00002","article-title":". HIV-associated sensory neuropathies.","volume":"16","author":"Keswani","year":"2002","journal-title":"AIDS"},{"key":"R8-5-20210131","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archneurol.2010.76","article-title":". Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the Charter Study.","volume":"67","author":"Ellis","year":"2010","journal-title":"Arch Neurol"},{"key":"R9-5-20210131","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0885-3924(99)00066-4","article-title":". Symptom prevalence, characteristics, and distress in AIDS outpatients.","volume":"18","author":"Vogl","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"R10-5-20210131","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/j.1468-1331.2007.01916.x","article-title":". EFNS guidelines on neurostimulation therapy for neuropathic pain.","volume":"14","author":"Cruccu","year":"2007","journal-title":"Eur J Neurol"},{"key":"R11-5-20210131","doi-asserted-by":"crossref","first-page":"E1113","DOI":"10.1111\/j.1468-1331.2010.02999.x","article-title":". EFNS guidelines on the pharmacological treatment of neuropathic pain: 2009 revision.","volume":"17","author":"Attal","year":"2010","journal-title":"Eur J Neurol"},{"key":"R12-5-20210131","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","article-title":". Pharmacologic management of neuropathic pain: evidence-based recommendations.","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"R13-5-20210131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":". Pharmacological management of chronic neuropathic pain: consensus statement and guidelines from the Canadian Pain Society.","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Res Manag"},{"key":"R14-5-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1533-2500.2006.00055.x","article-title":"Pharmacotherapy for neuropathic pain.","volume":"6","author":"Jackson","year":"2006","journal-title":"Pain Pract"},{"key":"R15-5-20210131","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"R16-5-20210131","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1212\/WNL.0b013e3181ccc6ef","article-title":". Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial.","volume":"74","author":"Simpson","year":"2010","journal-title":"Neurology"},{"key":"R17-5-20210131","doi-asserted-by":"crossref","first-page":"e14433","DOI":"10.1371\/journal.pone.0014433","article-title":". Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials.","volume":"5","author":"Phillips","year":"2010","journal-title":"PLoS One"},{"key":"R18-5-20210131","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1111\/j.1432-1033.2004.04082.x","article-title":"Biochemical pharmacology of the vanilloid receptor TRPV1. An update.","volume":"271","author":"Cortright","year":"2004","journal-title":"Eur J Biochem"},{"key":"R19-5-20210131","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3959(00)00311-0","article-title":". Capsaicin evoked pain and allodynia in post-herpetic neuralgia.","volume":"88","author":"Petersen","year":"2000","journal-title":"Pain"},{"key":"R20-5-20210131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2377-7-11","article-title":". Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy.","volume":"7","author":"Facer","year":"2007","journal-title":"BMC Neurol"},{"key":"R21-5-20210131","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2559.2007.02851.x","article-title":". Epidermal transient receptor potential vanilloid 1 in idiopathic small nerve fibre disease, diabetic neuropathy and healthy human subjects.","volume":"51","author":"Wilder-Smith","year":"2007","journal-title":"Histopathology"},{"key":"R22-5-20210131","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2165\/11206050-000000000-00000","article-title":"Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain.","volume":"70","author":"McCormack","year":"2010","journal-title":"Drugs"},{"key":"R24-5-20210131","first-page":"702","article-title":"NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain.","volume":"10","author":"Noto","year":"2009","journal-title":"Curr Opin Investig Drugs"},{"key":"R25-5-20210131","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jpainsymman.2007.04.015","article-title":". An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.","volume":"35","author":"Simpson","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"R26-5-20210131","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1212\/01.wnl.0000314647.35825.9c","article-title":"Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.","volume":"70","author":"Simpson","year":"2008","journal-title":"Neurology"},{"key":"R27-5-20210131","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jpainsymman.2009.11.316","article-title":". Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.","volume":"39","author":"Simpson","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"R28-5-20210131","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":". Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale.","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"R30-5-20210131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","article-title":"The short-form McGill pain questionnaire.","volume":"30","author":"Melzack","year":"1987","journal-title":"Pain"},{"key":"R31-5-20210131","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"R34-5-20210131","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2307\/2529259","article-title":"Symmetrical confidence intervals for bioequivalence trials.","volume":"32","author":"Westlake","year":"1976","journal-title":"Biometrics"},{"key":"R36-5-20210131","first-page":"351","article-title":"On the combination of independent two-sample tests of Wilcoxon.","volume":"37","author":"Van Elteren","year":"1960","journal-title":"Bull Int Stat Inst"},{"key":"R40-5-20210131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":". Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain"},{"key":"R41-5-20210131","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2010.07.031","article-title":". NeuPSIG guidelines on neuropathic pain assessment.","volume":"152","author":"Haanpaa","year":"2011","journal-title":"Pain"},{"key":"R42-5-20210131","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/FTD.0b013e3181a8b200","article-title":". Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain.","volume":"31","author":"Babbar","year":"2009","journal-title":"Ther Drug Monit"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-201202010-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:53:03Z","timestamp":1618037583000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201202010-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31823e31f7","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2,1]]}}}